brain

Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease

SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering at Day 84 on the 9mg daily oral…

1 week ago

FutureCeuticals Files Lawsuit Against NeuroRush Owner for Patent Infringement over Alleged Copycat Ingredient

MOMENCE, Ill., Sept. 15, 2025 /PRNewswire/ -- VDF FutureCeuticals, Inc. filed a lawsuit against Aura Scientific, asserting that its brain performance…

2 weeks ago

London musician with brain tumour inspires Brighton triathlon fundraiser

Tuesday 26 August, 2025 A talented musician from London, who died from a rare brain tumour in January this year…

1 month ago

Brain Navi Biotechnology’s NaoTrac performs first surgeries in Spain

Brain Navi has officially landed in Spain! TAIPEI, Aug.11, 2025 /PRNewswire/ -- Such an achievement has been made possible through…

1 month ago

FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025: U.S. POINTER STUDY SHOWS STRUCTURED LIFESTYLE PROGRAM TARGETING MULTIPLE RISK FACTORS IMPROVES COGNITION IN OLDER ADULTS AT RISK OF COGNITIVE DECLINE

Key Takeaways Two lifestyle interventions in U.S. POINTER improved cognition in older adults at risk of cognitive decline. A structured…

2 months ago

The World Federation of Neurology to Host Global Webinar Uniting UN-ECOSOC, WHO and Leading Brain Health Experts for World Brain Day 2025, with the theme Brain Health for All Ages

LONDON, July 18, 2025 /PRNewswire/ -- On July 22, the World Federation of Neurology (WFN) will celebrate its 12th annual…

2 months ago

Brain Navi achieves U.S. FDA approval for neurosurgical robot NaoTrac

ZHUBEI CITY, June 17, 2025 /PRNewswire/ -- Brain Navi Biotechnology, a medical robotics company founded in 2015 in Taiwan by surgeon…

3 months ago

Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development

NEW HAVEN, Conn., June 10, 2025 (GLOBE NEWSWIRE) -- Bexorg, Inc., a pioneering techbio company working to decode the human…

4 months ago

New Potential Treatment Strategy for Brain Metastases and Leptomeningeal Disease: HER3-DXd Shows Promising Results in the Phase II TUXEDO-3 Study for Patients With Limited Therapeutic Options

The TUXEDO-3 trial is the first study to evaluate the intracranial and extracranial efficacy and safety of a novel anti-cancer…

4 months ago

The Brain Prize: HM The King of Denmark presents prestigious prize to US and German scientists for seminal discoveries in brain cancer

Two pioneering scientists received The Brain Prize 2025 for their discoveries that open an entirely new way of thinking about…

4 months ago